Huang T-M, Chao S-C, Lee J Y-Y
Department of Dermatology, National Cheng-Kung University Hospital and College of Medicine, National Cheng-Kung University, Tainan, Taiwan.
Clin Exp Dermatol. 2009 Jan;34(1):77-80. doi: 10.1111/j.1365-2230.2008.02870.x.
Multiple familial trichoepithelioma (MFT) is an autosomal dominant disease characterized by numerous skin-coloured papules on the central face. Mutations in the CYLD gene, which is also the gene responsible for familial cylindromatosis, have been reported recently. Recent studies indicate that CYLD is a tumour-suppressor gene. The CYLD protein is a negative regulator of the activation of transcription factor nuclear factor-kappaB, and loss of CYLD contributes to oncogenesis. We report a novel splicing mutation (IVS12 + 1 G-->A) in the CYLD gene in a Taiwanese pedigree with MFT, and discuss new developments in treatment options.
多发性家族性毛发上皮瘤(MFT)是一种常染色体显性疾病,其特征为面部中央出现大量肤色丘疹。最近有报道称,CYLD基因发生突变,该基因也是家族性圆柱瘤的致病基因。近期研究表明,CYLD是一种肿瘤抑制基因。CYLD蛋白是转录因子核因子-κB激活的负调节因子,CYLD功能丧失会促进肿瘤发生。我们报告了一个患有MFT的台湾家系中CYLD基因的一种新型剪接突变(IVS12 + 1 G→A),并讨论了治疗方案的新进展。